Richard H. Hunt

Q: What Schools Are Affiliated With Richard H. Hunt

Richard H. Hunt is affiliated with the following schools: McMaster University

Richard H. Hunt's AcademicInfluence.com Rankings

Richard H. Hunt

Philosophy

#4515

World Rank

#7063

Historical Rank

Logic

#1949

World Rank

#2827

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Richard H. Hunt's Degrees

Doctorate Medicine Harvard University

Why Is Richard H. Hunt Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Richard H. Hunt's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

International Consensus Recommendations on the Management of Patients With Nonvariceal Upper Gastrointestinal Bleeding (2010) (1129)
Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer. (1998) (935)
Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: a meta-analysis. (1997) (853)
Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis (2002) (785)
Fecal Microbiota Transplantation for Clostridium difficile Infection: Systematic Review and Meta-Analysis (2013) (783)
The Toronto Consensus for the Treatment of Helicobacter pylori Infection in Adults. (2016) (643)
Second Asia–Pacific Consensus Guidelines for Helicobacter pylori infection (2009) (568)
Appropriate acid suppression for the management of gastro-oesophageal reflux disease. (1992) (558)
Guidelines for the management of Helicobacter pylori infection (1998) (492)
Helicobacter pylori eradication therapy to prevent gastric cancer in healthy asymptomatic infected individuals: systematic review and meta-analysis of randomised controlled trials (2014) (486)
Helicobacter pylori in developing countries. World Gastroenterology Organisation Global Guideline. (2011) (446)
Meta-analysis of the efficacy of antibiotic therapy in eradicating Helicobacter pylori. (1992) (378)
Is there an optimal degree of acid suppression for healing of duodenal ulcers? A model of the relationship between ulcer healing and acid suppression. (1990) (336)
Asia–Pacific consensus guidelines on gastric cancer prevention (2008) (322)
Expression of interleukin 8 and CD54 by human gastric epithelium after Helicobacter pylori infection in vitro. (1995) (298)
Meta-analysis of the relationship between cagA seropositivity and gastric cancer. (2003) (296)
Acid suppression in duodenal ulcer: a meta-analysis to define optimal dosing with antisecretory drugs. (1987) (282)
Canadian Consensus Conference on the management of gastroesophageal reflux disease in adults - update 2004. (2005) (247)
Bismuth-Based Quadruple Therapy Using a Single Capsule of Bismuth Biskalcitrate, Metronidazole, and Tetracycline Given With Omeprazole Versus Omeprazole, Amoxicillin, and Clarithromycin for Eradication of Helicobacter pylori in Duodenal Ulcer Patients: A Prospective, Randomized, Multicenter, North A (2003) (246)
Peptic ulcer disease today (2006) (237)
Multiparameter Flow Cytometric Analysis of Antibiotic Effects on Membrane Potential, Membrane Permeability, and Bacterial Counts of Staphylococcus aureus andMicrococcus luteus (2000) (232)
Nonsteroidal antiinflammatory drug-related injury to the gastrointestinal tract: clinical picture, pathogenesis, and prevention. (2010) (202)
Relationship between gastric secretion and infection. (1987) (199)
Endoscopic comparison of esophageal and gastroduodenal effects of risedronate and alendronate in postmenopausal women. (2000) (191)
Role of gastric acid suppression in the treatment of gastro-oesophageal reflux disease. (1992) (189)
Importance of pH control in the management of GERD. (1999) (188)
Asia‐Pacific consensus on the management of gastroesophageal reflux disease: Update (2007) (186)
Helicobacter pylori : basic mechanisms to clinical cure 2000 : the proceedings of a symposium organised by Axcan Pharma, held in Bermuda, March 26-29, 2000 (2000) (182)
Safe prescribing of non-steroidal anti-inflammatory drugs in patients with osteoarthritis – an expert consensus addressing benefits as well as gastrointestinal and cardiovascular risks (2015) (176)
The Effect of CYP2C19 Polymorphisms on H. pylori Eradication Rate in Dual and Triple First-Line PPI Therapies: A Meta-analysis (2006) (169)
Minimizing postcolonoscopy abdominal pain by using CO(2) insufflation: a prospective, randomized, double blind, controlled trial evaluating a new commercially available CO(2) delivery system. (2002) (169)
Comparison of the effects of ranitidine, cimetidine and placebo on the 24 hour intragastric acidity and nocturnal acid secretion in patients with duodenal ulcer. (1981) (160)
Canadian Association of Gastroenterology and the Canadian Digestive Health Foundation: Guidelines on colon cancer screening. (2004) (158)
Is There an Increased Risk of GERD After Helicobacter pylori Eradication?: A Meta-Analysis (2010) (156)
Gastric Cancer as Preventable Disease (2017) (153)
The effect of acupuncture on gastrointestinal function and disorders. (1992) (149)
Prospective comparison of double contrast barium enema plus flexible sigmoidoscopy v colonoscopy in rectal bleeding: barium enema v colonoscopy in rectal bleeding. (1988) (146)
Single nocturnal dose of an H2 receptor antagonist for the treatment of duodenal ulcer. (1983) (141)
Colonoscopy in the management of colon polyps (1974) (141)
Diagnosis and Management of Non-Erosive Reflux Disease – The Vevey NERD Consensus Group (2009) (139)
The Association Between Helicobacter pylori Infection and Early Gastric Cancer: A Meta-Analysis (2007) (139)
A Global Perspective on Irritable Bowel Syndrome: A Consensus Statement of the World Gastroenterology Organisation Summit Task Force on Irritable Bowel Syndrome (2012) (138)
Helicobacter pylori eradication for the prevention of gastric neoplasia. (2020) (136)
Canadian Helicobacter Study Group Consensus Conference on the Approach to Helicobacter pylori Infection in Children and Adolescents. (1999) (134)
World Gastroenterology Organisation Global Guidelines: GERD Global Perspective on Gastroesophageal Reflux Disease. (2017) (133)
Effects of gastroprotectant drugs for the prevention and treatment of peptic ulcer disease and its complications: a meta-analysis of randomised trials (2018) (132)
Treatment after failure: the problem of “non-responders” (1999) (131)
Can severity of symptoms be used as an outcome measure in trials of non-ulcer dyspepsia and Helicobacter pylori associated gastritis? (1993) (127)
Canadian Helicobacter pylori consensus conference. Canadian Association of Gastroenterology. (1998) (124)
What role does Helicobacter pylori play in dyspepsia and nonulcer dyspepsia? Arguments for and against H. pylori being associated with dyspeptic symptoms. (1997) (121)
Pharmacological and pharmacodynamic essentials of H(2)-receptor antagonists and proton pump inhibitors for the practising physician. (2001) (119)
Selective serotonin reuptake inhibitors and risk of upper GI bleeding: confusion or confounding? (2006) (116)
Report of the Asia–Pacific consensus on the management of gastroesophageal reflux disease (2004) (116)
Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report (2022) (115)
The relationship between the control of pH and healing and symptom relief in gastro‐oesophageal reflux disease (1995) (110)
The gastrointestinal safety of the COX-2 selective inhibitor etoricoxib assessed by both endoscopy and analysis of upper gastrointestinal events (2003) (110)
RANITIDINE 150 mg TWICE DAILY VS 300 mg NIGHTLY IN TREATMENT OF DUODENAL ULCERS (1984) (107)
Guidelines for clinical trials in Helicobacter pylori infection. Working Party of the European Helicobacter pylori Study Group. (1997) (106)
Systematic Reviews: The Good, the Bad, and the Ugly (2009) (105)
Canadian Helicobacter pylori Consensus Conference update: infections in adults. Canadian Helicobacter Study Group. (1999) (103)
Prevention of anti-inflammatory drug-induced gastrointestinal damage: benefits and risks of therapeutic strategies. (2006) (101)
Eradication of Helicobacter pylori infection. (1996) (94)
Consensus development conference on the use of nonsteroidal anti-inflammatory agents, including cyclooxygenase-2 enzyme inhibitors and aspirin. (2006) (93)
The role of Helicobacter pylori in pathogenesis: the spectrum of clinical outcomes. (1996) (89)
Small bowel and colonic permeability to 51Cr-EDTA in patients with active inflammatory bowel disease. (1988) (87)
Cost-effectiveness of Helicobacter pylori eradication for the long-term management of duodenal ulcer in Canada. (1995) (85)
Effect of immunologic reactions on rat intestinal epithelium. Correlation of increased permeability to chromium 51-labeled ethylenediaminetetraacetic acid and ovalbumin during acute inflammation and anaphylaxis. (1988) (84)
Reversibility of increased intestinal permeability to 51Cr-EDTA in patients with gastrointestinal inflammatory diseases. (1987) (82)
Effect on Intragastric pH of a PPI with a Prolonged Plasma Half-Life: Comparison between Tenatoprazole and Esomeprazole on the Duration of Acid Suppression in Healthy Male Volunteers (2005) (80)
PEPPERMINT OIL TO REDUCE COLONIC SPASM DURING ENDOSCOPY (1982) (79)
Proton pump inhibitors: the beginning of the end or the end of the beginning? (2008) (79)
Canadian Helicobacter Study Group Consensus Conference: Update on the management of Helicobacter pylori--an evidence-based evaluation of six topics relevant to clinical outcomes in patients evaluated for H pylori infection. (2004) (78)
Helicobacter pylori Infection and Barrett's Esophagus: A Systematic Review and Meta-Analysis (2009) (78)
Cerebral-evoked potential responses following direct vagal and esophageal electrical stimulation in humans. (1993) (77)
Endoscopic clipping for acute nonvariceal upper-GI bleeding: a meta-analysis and critical appraisal of randomized controlled trials. (2008) (77)
Helicobacter pylori Eradication Therapy (2002) (77)
A study to examine agreement between endoscopy and histology for the diagnosis of columnar lined (Barrett's) esophagus. (1989) (75)
Secretion of intravenously administered antibiotics in gastric juice: implications for management of Helicobacter pylori. (1992) (71)
14C-urea breath test for the detection of Helicobacter pylori. (1990) (71)
pH and Hp--gastric acid secretion and Helicobacter pylori: implications for ulcer healing and eradication of the organism. (1993) (71)
INTRAGASTRIC ACIDITY, BACTERIA, NITRITE, AND N-NITROSO COMPOUNDS BEFORE, DURING, AND AFTER CIMETIDINE TREATMENT (1982) (70)
Omeprazole (20 mg daily) versus cimetidine (1200 mg daily) in duodenal ulcer healing and pain relief. (1988) (68)
The gastrointestinal safety of the COX-2 selective inhibitor etoricoxib assessed by both endoscopy and analysis of upper gastrointestinal events. (2003) (67)
COVID-19 and Gastrointestinal Disease: Implications for the Gastroenterologist (2020) (67)
The Second Canadian Consensus Conference on the Management of Patients with Gastroesophageal Reflux Disease. (1997) (66)
Colonoscopy for unexplained rectal bleeding. (1978) (66)
The comparative effects of lansoprazole, omeprazole, and ranitidine in suppressing gastric acid secretion. (1997) (66)
The Esophagus Handbook and Atlas of Endoscopy (1979) (65)
pH, healing rate, and symptom relief in patients with GERD. (1999) (64)
Modulation of neurocardiac function by oesophageal stimulation in humans. (1997) (64)
Doctor–patient interaction for irritable bowel syndrome in primary care: a systematic perspective (2004) (62)
Cyclooxygenase-2 Inhibitors in Colorectal Cancer Prevention: Point (2008) (61)
14 day endoscopy study comparing risedronate and alendronate in postmenopausal women stratified by Helicobacter pylori status. (2002) (61)
Potassium-Competitive Acid Blockers (P-CABs): Are They Finally Ready for Prime Time in Acid-Related Disease? (2015) (59)
Review article: the unmet needs in delayed‐release proton‐pump inhibitor therapy in 2005 (2005) (56)
Alteration of H2 receptor sensitivity in duodenal ulcer patients after maintenance treatment with an H2 receptor antagonist. (1988) (55)
Comparison of twice-daily ranitidine with standard cimetidine treatment of duodenal ulcer. (1981) (53)
Multilaboratory Comparison of Proficiencies in Susceptibility Testing of Helicobacter pylori and Correlation between Agar Dilution and E Test Methods (2003) (52)
What is the quantitative risk of gastric cancer in the first-degree relatives of patients? A meta-analysis (2017) (52)
Evidence of Impaired Afferent Vagal Function in Patients with Diabetes Gastroparesis (1992) (51)
Myths and facts in the use of anti-inflammatory drugs (2009) (51)
HEALING OF GASTRIC ULCER DURING TREATMENT WITH CIMETIDINE (1976) (51)
A Canadian physician survey of dyspepsia management. (1998) (50)
Optimizing acid suppression for treatment of acid-related diseases (1995) (50)
Epidemic hypochlorhydria. (1985) (49)
Access to specialist gastroenterology care in Canada: comparison of wait times and consensus targets. (2008) (48)
Recommendations for the appropriate use of anti-inflammatory drugs in the era of the coxibs: defining the role of gastroprotective agents. (2002) (47)
Non-variceal upper gastrointestinal bleeding (2018) (46)
The correlation between acid suppression and peptic ulcer healing. (1986) (46)
Towards safer colonoscopy. (1983) (46)
The Esophageal and Gastric Microbiome in Health and Disease. (2017) (45)
Appropriate acid suppression for optimal healing of duodenal ulcer and gastro-oesophageal reflux disease. (1994) (45)
The effect of intravenous prostaglandin F2 alpha and E2 on the motility of the sigmoid colon. (1975) (45)
Effect of no treatment, cimetidine 1 g/day, cimetidine 2 g/day and cimetidine combined with atropine on nocturnal gastric secretion in cimetidine non-responders. (1984) (45)
Access to specialist gastroenterology care in Canada: the Practice Audit in Gastroenterology (PAGE) Wait Times Program. (2008) (45)
Changes in intestinal permeability and epithelial differentiation during inflammation in the rat. (1988) (44)
The effect of eradication of Helicobacter pylori (Hp) on symptoms of non-ulcer dyspepsia (NUD): A randomized double-blind placebo controlled trial (1995) (44)
World Gastroenterology Organisation global guidelines on obesity. (2012) (44)
Helicobacter pylori in First Nations and recent immigrant populations in Canada. (2012) (43)
Cimetidine or vagotomy? Comparison of the effects of proximal gastric vagotomy, cimetidine and placebo on nocturnal intragastric acidity and acid secretion in patients with cimetidine resistant duodenal ulcer (1983) (43)
Hp and pH: implications for the eradication of Helicobacter pylori. (1993) (42)
World Gastroenterology Organisation Global Guidelines Helicobacter pylori in developing countries August 2010 : WGO global guidelines (2011) (41)
The Gain in Quality-Adjusted Life Months by Switching to Esomeprazole in Those With Continued Reflux Symptoms in Primary Care: EncomPASS—A Cluster-Randomized Trial (2010) (41)
24-hour intragastric acidity and nocturnal acid secretion in patients with duodenal ulcer during oral administration of cimetidine and atropine. (1977) (41)
Hormonal therapy for bleeding gastrointestinal mucosal vascular abnormalities: a promising alternative. (1997) (41)
Gastrointestinal safety profile of nabumetone: a meta-analysis. (1999) (39)
Canadian Association of Gastroenterology position statement: fecal microbiota transplant therapy. (2014) (39)
Replication-Defective Adenovirus Infection ReducesHelicobacter felis Colonization in the Mouse in a Gamma Interferon- and Interleukin-12-Dependent Manner (1999) (39)
Review: Eradication of Helicobacter pylori. Problems and recommendations (1997) (39)
Accuracy and value of the Hemoccult test in symptomatic patients. (1983) (38)
The Second Canadian Gastroesophageal Reflux Disease Consensus: moving forward to new concepts. (1998) (38)
Helicobacter pylori Public Health Implications (2004) (38)
pH, healing rate and symptom relief in acid-related diseases. (1996) (38)
Helicobacter pylori and gastric acid secretion: the ulcer link? (1991) (37)
Evolving concepts in functional gastrointestinal disorders: promising directions for novel pharmaceutical treatments. (2002) (37)
Helicobacter pylori: new developments and treatments. (1997) (35)
Antigen-induced mucosal damage and restitution in the small intestine of the immunized rat. (1990) (35)
The treatment of gastric ulcer with antisecretory drugs (1988) (35)
Effect of Th1 cytokines on acid secretion in pharmacologically characterised mouse gastric glands (2004) (35)
Colonoscopy in management of colonic strictures. (1975) (34)
An orally active non-selective endothelin receptor antagonist, bosentan, markedly reduces injury in a rat model of colitis. (1996) (34)
Initial therapy and relapse of duodenal ulcer: possible acid secretory mechanisms. (1989) (34)
Peptic ulceration in patients with chronic liver disease (1980) (34)
Association of myocardial infarctions with COX-2 inhibition may be related to immunomodulation towards a Th1 response resulting in atheromatous plaque instability: an evidence-based interpretation. (2010) (34)
The protective role of gastric acid. (1988) (33)
Potent Acid Suppression with PPIs and P-CABs: What’s New? (2018) (32)
Coping with common gastrointestinal symptoms in the community: a global perspective on heartburn, constipation, bloating, and abdominal pain/discomfort May 2013. (2014) (32)
Management of Reflux Symptoms with Over-the-Counter Proton Pump Inhibitors: Issues and Proposed Guidelines (2009) (31)
A brief history of endoscopy (2001) (31)
Effect of acupuncture on gastric acid secretion in healthy male volunteers (1992) (31)
Will eradication of Helicobacter pylori infection influence the risk of gastric cancer? (2004) (31)
Effect of immunologic reactions on rat intestinal epithelium (1988) (30)
Critical issues in the pathophysiology and management of peptic ulcer disease. (1995) (30)
Review of the emerging treatment of Clostridium difficile infection with fecal microbiota transplantation and insights into future challenges. (2014) (30)
Aspects of the theoretical basis and clinical relevance of low acid states. (1994) (30)
Peptic ulcer disease: defining the treatment strategies in the era of Helicobacter pylori. (1997) (30)
Do patients with non-ulcer dyspepsia respond differently to Helicobacter pylori eradication treatments from those with peptic ulcer disease? A systematic review. (2005) (29)
Neurophysiological Effects of Left Vagal Stimulation in Man (1991) (29)
Approach to managing musculoskeletal pain: acetaminophen, cyclooxygenase-2 inhibitors, or traditional NSAIDs? (2007) (29)
Optimization of a medium for the rapid urease test for detection of Campylobacter pylori in gastric antral biopsies (1989) (28)
A prospective comparison of symptoms and five diagnostic tests in patients with Helicobacter pylori positive and negative dyspepsia (1991) (28)
Effects of Smoking on Cure of Helicobacter pylori Infection and Duodenal Uulcer Recurrence in Patients Treated with Clarithromycin and Omeprazole (1997) (28)
Bismuth-based quadruple therapy with bismuth subcitrate, metronidazole, tetracycline and omeprazole in the eradication of Helicobacter pylori. (2001) (27)
Oxmetidine: clinical pharmacological studies with a new H2-receptor antagonist. (1982) (27)
Medical management of gastroesophageal reflux disease. (2008) (27)
Practical considerations for the use of nonsteroidal anti-inflammatory drugs and cyclo-oxygenase-2 inhibitors in hypertension and kidney disease. (2002) (27)
Non-Erosive Reflux Disease – Defining the Entity and Delineating the Management (2008) (26)
Has education about Helicobacter pylori infection been effective? Worldwide survey of primary care physicians (2003) (26)
Acid suppression for reflux disease: "off-the-peg" or a tailored approach? (2012) (25)
Can gastritis symptoms be evaluated in clinical trials? An overview of treatment of gastritis, nonulcer dyspepsia and Campylobacter-associated gastritis. (1989) (25)
Progress with proton pump inhibition. (1992) (25)
Therapeutic effects of the endothelin receptor antagonist Ro 48‐5695 in the TNBS/DNBS rat model of colitis (2000) (24)
Review and analysis of the effects of olestra, a dietary fat substitute, on gastrointestinal function and symptoms. (1997) (24)
Evolving issues in the management of reflux disease? (2009) (24)
Therapeutic Endoscopy and Radiology of the Gut (1981) (23)
Environment and Life Style - Effects on Disorders of the Digestive Tract (2010) (23)
Evolving concepts in the pathophysiology of functional gastrointestinal disorder. (2002) (22)
Gastric secretory studies in humans with impromidine (SK&F 92676)--a specific histamine H2 receptor agonist. (1980) (22)
Precise Role of Acid in Non-Erosive Reflux Disease (2008) (22)
Control of pepsinogen synthesis and secretion. (1990) (22)
Adding once-daily omeprazole 20 mg to metronidazole/amoxicillin treatment for Helicobacter pylori gastritis: a randomized, double-blind trial showing the importance of metronidazole resistance. (1998) (21)
Prevalence, impact and attitudes toward lower gastrointestinal dysmotility and sensory symptoms, and their treatment in Canada: A descriptive study. (2007) (21)
Outcome of patients discharged from a coronary care unit with a diagnosis of "chest pain not yet diagnosed". (1996) (21)
Adding Once-Daily Omeprazole 20 mg to Metronidazole/Amoxicillin Treatment for Helicobacter pylori Gastritis: A Randomized, Double-Blind Trial Showing the Importance of Metronidazole Resistance (1998) (20)
Effects of Chronic Left Vagal Stimulation on Visceral Vagal Function in Man (1992) (20)
The potential role of potassium-competitive acid blockers in the treatment of gastroesophageal reflux disease. (2019) (20)
Acid-NSAID/Aspirin Interaction in Peptic Ulcer Disease (2011) (19)
Controlled comparison of cimetidine and carbenoxolone sodium in gastric ulcer. (1979) (19)
Diagnostic approach to evaluating the cause of a positive fecal occult blood test (1984) (19)
Effect of hydrochloric acid and prostaglandins on pepsinogen synthesis and secretion in canine gastric chief cell monolayer cultures. (1989) (19)
Colonoscopic diagnosis of inflammatory bowel disease. (1982) (19)
Helicobacter pylori eradication: a critical appraisal and current concerns. (1995) (19)
Etiology of dyspepsia: implications for empirical therapy. (2002) (18)
Economic Evaluation of Long Term Management Strategies for Erosive Oesophagitis (1999) (18)
Cortical Evoked Responses Following Esophageal Balloon Distension and Electrical Stimulation in Healthy Volunteers (1998) (18)
Bismuth-based triple therapy with bismuth subcitrate, metronidazole and tetracycline in the eradication of Helicobacter pylori: a randomized, placebo controlled, double-blind study. (2000) (18)
Implications of antibiotic resistance in the management of Helicobacter pylori infection: Canadian Helicobacter Study Group. (2000) (18)
Effects of low dose omeprazole on gastric secretion and plasma gastrin in patients with healed duodenal ulcer. (1986) (18)
Practice Audit in Gastroenterology (PAGE) program: a novel approach to continuing professional development. (2006) (17)
The current role of Helicobacter pylori eradication in clinical practice. (1995) (17)
Colonoscopy : techniques, clinical practice, and colour atlas (1981) (17)
Relationship between inhibition of acid secretion and healing of peptic ulcers. (1989) (17)
Helicobacter pylori and the prevention of gastric cancer. (2004) (17)
Navigating Long-Term Safety in Fecal Microbiota Transplantation (2013) (17)
Time course and pattern of blood loss with ibuprofen treatment in healthy subjects. (2005) (16)
Endoscopy of the esophagus in gastroesophageal reflux disease: are we losing sight of symptoms? Another perspective. (2009) (16)
Risks and benefits of Helicobacter pylori eradication: current status. (2002) (16)
Histamine H2 receptors and intrinsic factor secretion. (1980) (16)
Sucralfate: The Bangkok review (1994) (16)
Management of NSAID induced gastrointestinal disturbance. (1987) (15)
The evolving epidemiology of Helicobacter pylori infection and gastric cancer. (2003) (15)
The evolving epidemiology of Helicobacter pylori infection and gastric cancer (2003) (15)
The effect of temperature and pH on the stability of human pepsin in stored gastric juice. A method to prevent activity loss. (1986) (15)
Comparison of ranitidine and cimetidine maintenance treatment of duodenal ulcer. (1984) (15)
Cyclooxygenase-2 Inhibitors in Colorectal Cancer Prevention: Counterpoint (2008) (15)
Chapter Twenty – Treatment of non-NSAID and non-H. pylori gastroduodenal ulcers and hypersecretory states (2006) (14)
Effect of Purified Lipopolysaccharides from Strains of Helicobacter pylori and Helicobacter felis on Acid Secretion in Mouse Gastric Glands In Vitro (2001) (14)
Is intrinsic factor really affected by cimetidine? (1979) (14)
Hp and pH--the relevance of gastric acid to the treatment of Helicobacter pylori infection. (1994) (14)
Inhibition of urease activity but not growth of Helicobacter pylori by acetohydroxamic acid. (1991) (14)
Editorial: towards extended acid suppression – the search continues (2015) (14)
Helicobacter pylori and gastric neoplasia: evolving concepts (1995) (14)
Smoking and duodenal ulcer disease. (1989) (14)
The effect of ranitidine and cimetidine on the twenty-four hour intragastric acidity profile and nocturnal acid secretion in duodenal ulcer patients. (1981) (14)
Helicobacter pylori infection in adolescents with eating disorders and dyspeptic symptoms. (1993) (14)
CanadianHelicobacter pyloriConsensus Conference (1998) (14)
GERD: New Strategies and New Failures (2007) (14)
Comparison of the effects of gastric antisecretory agents in healthy volunteers and patients with duodenal ulcer. (1986) (13)
A systematic overview of the use of diary cards, quality-of-life questionnaires, and psychometric tests in treatment trials of Helicobacter pylori-positive and -negative non-ulcer dyspepsia. (1998) (13)
Consensus Report infection: the Maastricht III Helicobacter pylori Current concepts in the management of (2007) (13)
Transient ischaemic colitis--colonoscopy and biopsy in diagnosis. (1979) (13)
Endoscopic sphincterotomy for bile duct stones. (1980) (13)
Acquired double pylorus. (1978) (13)
Effect of Aspirin and ibuprofen either alone or in combination on gastric mucosa and bleeding time and on serum prostaglandin E2 and thromboxane A2 levels in the anaesthetized rats in vivo (2017) (13)
Do H2 receptor antagonists have to be given at night? A study of the antisecretory profile of SKF 94482, a new H2 receptor antagonist which has a profound effect on daytime acidity. (1989) (13)
Ranitidine bismuth citrate. (2001) (12)
Treatment of peptic ulcer disease with sucralfate: a review. (1991) (12)
H1 contractile and H2 relaxant receptors in canine gastric muscularis mucosae. (1993) (12)
Exocrine Pancreatic Function Tests: A Review (1989) (12)
Helicobacter pylori and dyspepsia: a conceptual approach (1996) (12)
International Consensus on Guiding Recommendations for Management of Patients with Nonsteroidal Antiinflammatory Drugs Induced Gastropathy-ICON-G (2018) (12)
Why guidelines are required for the treatment of Helicobacter pylori infection in children. (1996) (12)
Nocturnal gastric acid secretion: its importance in the pathophysiology and rational therapy of duodenal ulcer. (1986) (12)
Pharmacologic treatment of GERD: Where we are now, and where are we going? (2020) (11)
Pharmacokinetics and pharmacodynamics of treatments for peptic ulcer disease in the elderly. (1988) (11)
GERD Evaluation: Time for a New Paradigm? (2007) (11)
A Systematic Overview of the Use of Diary Cards, Quality-of-Life Questionnaires, and Psychometric Tests in Treatment Trials of Helicobacter pylori-Positive and -Negative Non-Ulcer Dyspepsia (1999) (11)
COX-2 specific inhibition with MK-0663 120 Mg Q.D. Over 4 weeks did not increase fecal blood loss: A controlled study with placebo and ibuprofen 800 Mg T.I.D. (2001) (11)
Overview of olestra: a new fat substitute. (1998) (11)
Editorial: potassium‐competitive acid blockers for acid‐related diseases—tegoprazan, a new kid on the block (2019) (11)
Medical regimens in short- and long-term ulcer management. (1988) (11)
W1100 Intragastric pH Holding Time of pH <4 Predicts Low Erosive Esophagitis (EE) Healing Rate (2010) (11)
helicobacter pylori: a workshop review (1993) (10)
Impact of oesophagitis classification in evaluating healing of erosive oesophagitis after therapy with proton pump inhibitors: a pooled analysis (2010) (10)
Recent advances in Barrett's esophagus (2018) (10)
Cost effectiveness of alternative Helicobacter pylori eradication strategies in the management of duodenal ulcer. (1997) (10)
M1893 Non-Healed Rate of Moderate-Severe (LA Classification Grade C and D) Erosive Esophagitis After 4-8 Weeks Proton Pump Inhibitors (PPIs): Evidence of An Unmet Need (2009) (10)
Helicobacter pylori : from theory to practice : proceedings of a symposium (1996) (10)
Establishment of T‐Helper‐2 immune response based gerbil model of enteric infection (2004) (10)
Coping with common GI symptoms in the community A global perspective on heartburn, constipation, bloating, and abdominal pain/discomfort (2013) (10)
Eradication of Helicobacter pylori infection in the management of patients with dyspepsia and non-ulcer dyspepsia. (1998) (10)
Intragastric Acid Suppressing Effect of Proton Pump Inhibitors Twice Daily at Steady State in Healthy Volunteers: Evidence of an Unmet Need? (2008) (10)
A double-blind randomized study comparing different dose regimens of H2-receptor antagonists on 24-hour gastric secretion in normal subjects and duodenal ulcer patients. (1987) (10)
Isolation and partial characterization of gastrotropin from canine ileum: further studies of the parietal and chief cell response. (1988) (9)
Assessment of the safety of selective cyclo-oxygenase-2 inhibitors: where are we in 2003? (2004) (9)
Effect of transdermally administered hyoscine methobromide on nocturnal acid secretion in patients with duodenal ulcer. (1982) (9)
Barrett's esophagus: proton pump inhibitors and chemoprevention II (2011) (9)
Critical reappraisal of mucosal repair mechanisms. (1995) (9)
S1085 The Proportion of Patients Who Are Free of Reflux Symptoms During the Initial Days of Treatment with Proton Pump Inhibitors (PPIs) in GERD Trials: A Meta-Analysis (2008) (9)
Global gastrointestinal safety profile of etoricoxib and lumiracoxib. (2007) (9)
Does misoprostol given as a single large dose improve its antisecretory effect? (1989) (9)
Effects of chronic NSAIDs on gastric mucosal injury related to mucosal prostanoids, and plasma drug concentrations in human volunteers (2005) (9)
Whistler Summary: “The Slow Rate of Rapid Progress” (2007) (8)
Acid, bacteria and the mucosal barrier: aspiration or translocation as the cause of pneumonia? (1992) (8)
Habit, prejudice, power and politics: issues in the conversion of H2-receptor antagonists to over-the-counter use. (1996) (8)
Drug Therapy of Helicobacter pylori Infection: A Meta-Analysis (1999) (8)
The effect of naloxone on lipid-induced pyloric motor response in humans. (1990) (8)
Acid and barriers. Current research and future developments for peptic ulcer therapy. (1990) (8)
S1093 Dose-Effect of S-Tenatoprazole-Na in Healthy Volunteers: A Meta-Analysis of Individual Subject Data from Four Pharmacodynamic Studies (2008) (8)
Role of Helicobacter pylori infection in NSAID-associated gastropathy (2000) (7)
World Gastroenterology Organisation Global Guideline: Helicobacter pylori in developing countries. (2011) (7)
Do hourly averaged pH readings correlate with those from point readings of aspiration? Comparison of two different electrode positions with simultaneous aspiration. (1990) (7)
Role of T lymphocytes in intestinal mucosal injury (2005) (7)
Adenosine A1 receptors are not involved in contraction of canine gastric muscularis mucosae by adenosine analogues. (1994) (7)
Inhibition of Helicobacter pylori by acetohydroxamic acid (1990) (7)
Cimetidine or vagotomy? (1984) (7)
Recurrent retching with gastric mucosal prolapse: a proposed prolapse gastropathy syndrome, H.A. Shepherd, J. Harvey, A. Jackson, D.G. Collin-Jones, in: Dig Dis Sci, 29. (1984), 121 (1985) (7)
The drug treatment of duodenal ulcer: physiological considerations in the choice of therapy. (1986) (7)
Campylobacter pylori infection. (1988) (7)
An overview of Helicobacter pylori epidemiology studies (1998) (7)
Acid Suppressant Therapy: a Step Forward with Potassium-Competitive Acid Blockers (2021) (7)
Medical Management of Gastroesophageal Reflux (2008) (7)
Stability of gastric-juice pepsin, and a method for its preservation. (1984) (6)
NSAID--induced gastroduodenal ulcers: exploring the silent dilemma. (1994) (6)
Gastrointestinal pharmacology: practical tips for the esophagologist (2020) (6)
Editorial: healing of refractory reflux oesophagitis – an ongoing unmet clinical need (2014) (6)
Single nocturnal doses of pirenzepine effectively inhibit overnight gastric secretion. (1985) (6)
Zinc Compounds Combined With Cyclodextrin Inhibit Growth of Helicobacter pylori In-vitro (1997) (6)
Acid‐related disorders in the new millennium: European, Japanese and North American perspectives (1998) (6)
Peptic ulcer in the Royal Navy. (1981) (5)
Host-specific differences in the physiology of acid secretion related to prostaglandins may play a role in gastric inflammation and injury. (2005) (5)
The risk of upper gastrointestinal haemorrhage during steroidal and non-steroidal anti-inflammatory therapy. (1990) (5)
Morth American randomized trial of single-triple capsule (bismuth subcitrate, metronidazele, tetracycline) plus omeprazole vs. Omeprazole, amoxicillin, and clarithremycin for H. pylori eradication (2001) (5)
Night-Time pH Holding Time: What Is Hidden by the% of Time pH ≤ 4? (2008) (5)
Quality of Life--the challenges ahead. (1993) (5)
Comparison of Omeprazole with Ranitidine for Treatment of Symptoms Associated with Gastroesophageal Reflux Disease and Uncomplicated Duodenal Ulcer (1996) (5)
A Colour Atlas of Gastrointestinal Endoscopy (1987) (5)
The role of colonoscopy in complicated diverticular disease. A review. (1979) (5)
Gastric secretion in patients with typhoid. (1985) (5)
The effects of intravenous famotidine on pentagastrin‐stimulated gastric secretion in man (1987) (5)
Principles and practice of gastroenterology and hepatology. 2nd ed.: Edited by Gary Gitnick, Daniel Hollander, I. Michael Samloff, Leslie J. Schoenfield, and John M. Vierling. Appleton & Lange, East Norwalk, Connecticut, 1994. ISBN 0-8385-8064-5 (1995) (5)
Acid suppression. (1990) (5)
Introduction to Scandinavian Journal of Gastroenterology Supplement ‘Horizons in Gastroenterology’ (1990) (5)
Validation of pH dataloggers for pharmacologic studies. (1989) (5)
Use of Antisecretory Medication after Antireflux Surgery for Patients with Gastroesophageal Reflux Disease (GERD): A Systematic Review of Randomized Control Trials (RCTs): 59 (2009) (4)
Effects of non-steroidal anti-inflammatory drugs on prostaglandin h synthase isoenzyme 2 (cyclo-oxygenase 2) production by porcine gastric mucosa in organ culture (1995) (4)
Role of endoscopy in the diagnosis of cancer: a consensus statement prepared by a working party of the International Union against Cancer. (1989) (4)
Motion--Cyclo-oxygenase-2 selective nonsteroidal anti-inflammatory drugs are as safe as placebo for the stomach: arguments for the motion. (2003) (4)
NSAID-Induced Gastric Ulcers: Exploring the Silent Dilemma (1990) (4)
M1900 Intragastric pH Holding Time pH <3 At Steady State in Healthy Volunteers (HV) After Once Daily PPIs: A Predictor for Low Erosive Esophagitis (EE) Healing Rates? (2009) (4)
A presentation of latent tropical sprue in a Canadian hospital (2013) (4)
W1093 Helicobacter pylori Eradication Reduces the Incidence of Gastric Cancer: Results of a Systematic Review of Randomized Controlled Trials (2008) (4)
Exocrine pancreatic function tests. (1989) (4)
The case for treatment of dyspeptic patients infected with H. pylori. (2003) (4)
Editorial: acid suppression with potassium‐competitive acid blockers dismissing genotype concerns (2021) (4)
How does smoking harm the duodenum? (1988) (4)
Comparison of different strategies for treating duodenal ulcer (1985) (3)
Editorial: Uses and abuses of meta-analysis in gastroenterology (2002) (3)
Inflammation, acid and ulcers. (1994) (3)
W1114 Antisecretory Effects of Lactobacillus rhamnosus Conditioned Medium Prompts the Notion of Lactobacilli Species as Probiotics of the Upper GI Tract (2010) (3)
Comparison oftwice-daily ranitidine withstandard cimetidine treatment ofduodenal ulcer (1981) (3)
The limitations of current therapy in peptic ulcer disease. (1987) (3)
A clinician’s view of strategies for preventing NSAID-induced gastrointestinal ulcers (1996) (3)
Practice guidelines Guidelines for the Management of Helicobacter pylori Infection (1998) (3)
Impromidine (SK&F 92676)--a potent and highly selective histamine H2-receptor agonist in man [proceedings]. (1979) (3)
The effect of H2-receptor antagonists on pepsin secretion in man. (1985) (3)
Rabeprazole extended‐release 50 mg compared with esomeprazole 40 mg and rabeprazole delayed release 20 mg (2011) (3)
M1894 An Updated Model of Intragastric pH and Erosive Esophagitis (EE) Healing Using 24-Hour Intragastric pH Values to Predict EE Healing: Validation By Data from TAK-390MR (2009) (3)
Relation of acupuncture and vagal gastric acid secretion. (1995) (3)
1078 Risk of Serious Upper Gastrointestinal (UGI) Complications in Patients Receiving Non-Selective NSAIDs for at Least 4 Weeks: A Series of Systematic Reviews of Randomized Controlled Trials (RCT), Cohort Studies and Case Control Studies (2012) (3)
Helicobactor pylori (2003) (3)
Helicobacter pylori infection and Barrett's esophagus: a meta-analysis (2003) (3)
Obscure gastrointestinal bleeding: an approach to management. (2000) (3)
Angiodysplasia in the colon and rectum — endoscopic morphology, localization and frequency, W. Hochter, J. Weingart, W. Kuhner, E. Frimberger, R. Ottenjann, in: Endoscopy, 17. (1985), 182 (1986) (3)
Helicobacter pylori World Gastroenterology Organization Global Guideline. (2022) (3)
Changes inintestinal permeability andepithelial differentiation during inflammation intherat (1988) (2)
H2 receptor antagonists—cimetidine and ranitidine (1983) (2)
Helicobacter pylori and immigrant health (2012) (2)
S1096 Symptom Relief Assessed By Reflux Questionnaire (Request™): A Superior Clinical Endpoint Compared to Investigator-Assessed Heartburn? (2008) (2)
Controversial issues in gastroesophageal reflux disease. (1997) (2)
Consensus Report Helicobacter pylori infection - The Maastricht III Current concepts in the management of (2007) (2)
Enprostil and ranitidine in duodenal ulcer healing. (1986) (2)
PWE-079 Use of antisecretory medication after antireflux surgery for patients with gastro-oesophageal reflux disease: a systematic review of non-randomised studies (2010) (2)
Randomized Controlled Trials (2011) (2)
Reduction of intragastric acidity in duodenal ulcer. Cimetidine or surgery? (1978) (2)
Efficacy of colloidal bismuth subcitrate, metronidazole, and tetracycline HCl in eradication of H. pylori: A randomized, placebo-controlled study (1998) (2)
Mucosal damage during intestinal anaphylaxis in the rat (1992) (2)
Relapse of duodenal ulcer (1986) (2)
Accuracy and value of the Haemoccult test in symptomatic patients (1983) (2)
Review article: the risks of oesophageal acid exposure ‐ from minimal mucosal changes to malignancy (2007) (2)
Consensus Statement on Helicobacter pylori infection and its management. (1997) (2)
Hemophagocytic Lymphohistiocytic Syndrome and Enteropathy-Associated T-cell Lymphoma in a Patient with Refractory Celiac Disease (2014) (2)
The Canine Gastric Muscularis Mucosae and Acid Secretion: A Basket Case? (1994) (2)
Abstracts of the sixth international conference on experimental ulcer (1988) (2)
Proton pump inhibitor and clopidogrel interaction: The case for watchful waiting (2010) (2)
Inaccurate endoscopy: a better explanation for placebo‐associated endoscopic ulcers: authors’ reply (2009) (2)
Use and Abuse of H2 Receptor Antagonists (1982) (2)
Control of pepsinogen synthesis and secretion in primary monolayer cultures of canine gastric chief cells (1988) (2)
A Physiological Basis for the Rational Therapy of Peptic Ulcer (1986) (2)
Randomized controlled trials of the medical treatment of cirrhotic ascites (1991) (2)
Therapeutic effect of endothelin receptor antagonist ro 48-5695 in rat model of colitis (1998) (2)
Practical Gastrointestinal Endoscopy (1980) (2)
AGN 201904-Z (AGN), a Novel Enteric-Coated PPI, Produces Greater, More Prolonged Acid Suppression Than Esomeprazole (ESO) in Healthy Male Volunteers: 149 (2006) (2)
Endoscopy study comparing risedronate andalendronate in postmenopausal women (2000) (2)
M1890 Improvement in Sleep Disturbance in Patients with Persistent GERD Symptoms After a Change in Therapy: EncomPASS - a Cluster-Randomized Study in Primary Care (2009) (1)
A dynamic analysis of area under the curve (AUC) estimation of hydrogen ion activity predicts mucosal damage in GERD (1994) (1)
Cost Effectiveness in Canada of a Multidrug Prepackaged Regimen (Hp-PAC®) for Helicobacter pylori Eradication (2012) (1)
Commentary: independent risk factors for recurrent neoplasia after endoscopic resection of early gastric cancer (2014) (1)
Acetaminophen and aminotransferase elevations. (2006) (1)
Concurrent Lower Gastrointestinal Bleeding Risk and Myocardial Ischemic Risk: Resume Aspirin or Not? (2016) (1)
The NERD Task Force: Overview and Consensus: Vevey, November-December 2007 (2008) (1)
Accuracy and value of the Haemoccult test (1983) (1)
Editorial: slow progress to optimising H. pylori eradication treatment with antisecretory drugs (2022) (1)
Effect of high salt diet on the colonization and pathological changes of gastric mucosa in Mongolian gerbils infected with the Sydney strain of Helicobacter pylori (2002) (1)
Su1771 Risk of Serious Upper Gastrointestinal (UGI) Complications With Concomitant Non-Selective NSAID and Anticoagulation Therapy for at Least 4 Weeks: A Series of Systematic Reviews of Randomized Controlled Trials (RCT), Cohort Studies and Case Control Studies (2012) (1)
Helicobacter pylori and ulcerogenesis. Discussion (1996) (1)
Socioeconomic Burden of digestive disorders in Canada: A retrospective and descriptive analysis (2003) (1)
Scientific Requirements for Diagnostic Tests in Gastroenterology (1986) (1)
The effect of cimetidine on pepsin secretion in patients with Zollinger Ellison syndrome. (1983) (1)
Helicobacter pylori eradication for the prevention of gastric neoplasia. (2020) (1)
Su1607 Risk of Serious Upper Gastrointestinal (UGI) Complications With Concomitant use of Non-Selective NSAIDs and Clopidogrel for at Least 4 Weeks: A Series of Systematic Reviews of Randomized Controlled Trials (RCT), Cohort Studies and Case Control Studies (2012) (1)
Chronic Administration of Diclofenac Did Not Result in Gastric Damage but Increased Cardiovascular Risk by Upregulation of PRO-Atherogenic Cytokines. (2011) (1)
Flexible sigmoidoscopy in outpatients with suspected colonic disease (1981) (1)
Media for the culture of Campylobacter pylori. (1989) (1)
Visceral deposition of schistosome ova in Central Africans. (1965) (1)
Studies on the cimetidine resistant duodenal ulcer: a summary of work performed at the Royal Naval Hospital, Haslar. (1984) (1)
Clinical impact of CYP2C19 polymorphism on the action of proton pump inhibitors: a review of a special problem. (2007) (1)
What Is the Truth? Sleep Disturbance as Assessed by Investigators or a Validated Instrument (ReQuest™) in Patients with GERD: 17 (2007) (1)
Omeprazole and Acid Inhibition: The Essential Issues (1991) (1)
The epidemiology and pathogenesis of gastric ulcer. (1980) (1)
Pd 135154 a potent competitive antagonist of peripheral gastrin receptors (1991) (1)
H. PYLORI INFECTION, GASTRIC CANCER AND GASTRIC MALT LYMPHOMA (2000) (1)
Evidence-based gastroenterology (2013) (1)
Stress and the enteron. (1974) (1)
Su1776 Risk of Serious Upper Gastrointestinal (UGI) Complications in Patients Receiving Multiple Non-Selective NSAIDs for at Least 4 Weeks: A Series of Systematic Reviews and Meta-Analyses of Randomized Controlled Trials (RCT), Cohort and Case Control Studies (2012) (1)
Has education about H. pylori (Hp) infection been effective? — A worldwide survey of primary care physicians (PCPs) (2001) (1)
Helicobacter pylori (2000) (1)
Spontaneous hypochlorhydria in man: possible causes and consequences. (1986) (1)
Helicobacter pylori Eradication and Change in Body Weight: A Systematic Review (2011) (1)
Response to Fuccio et al. (2009) (1)
Surveillance for colonic carcinoma in ulcerative colitis, E. Rosenstock, R.G. Farmer, R. Petras, M.V. Sivak, G.B. Rankin, B.H. Sullivan, in: Gastroenterology, 89. (1985), 1342 (1986) (1)
The use of a polaroid camera for gastrointestinal endoscopy. (1984) (1)
Effect of purified forms of lipopolysaccharide from various strains of Helicobacter pylori and Helicobacter felis on acid secretion in vitro (2000) (1)
A Balancing View: Evidence-Based Medicine: Neither Savior Nor Scourge but a Practical Tool for Clinical Practice (2008) (1)
M1937 Risk of Development of Gastric Cancer in Relatives of Patients with Non-Hereditary Gastric Cancer: A Meta-Analysis (2009) (1)
M1870 Resolution of Persistent GERD Symptoms After a Change in Therapy: EncomPASS - a Cluster-Randomized Study in Primary Care (2009) (1)
Refractory Duodenal Ulcer (1991) (1)
The effect of tripotassium dicitrato bismuthate on pepsin activity (1989) (1)
Marked suppression of stimulated gastric acid and pepsin secretion by enisoprost, a new PGE1 analogue (1987) (1)
Was It Really an Ugly Meta-Analysis? Authors' reply (2009) (1)
Treating Helicobacter pylori. (1998) (1)
M1691 Is There a Relationship Between H. pylori Prevalence and Overweight? A Systematic Review of Observational Studies (2010) (1)
World Digestive Health Day 2012. (2012) (1)
Healing rates for moderate and severe oesophagitis: author's reply (2006) (1)
Re-analysis of application of haemoclips for non-variceal upper gastrointestinal bleeding data. (2008) (1)
Effect of Proton Pump Inhibitors (PPIs) Treatment on the Length of Barrett's Esophagus: A Systematic Review of Cohort Studies (2011) (1)
Rationalizing Cyclooxygenase Inhibition for Optimization of Efficacy and Safety ProfilesIntroduction (1999) (1)
LOWER GI SYMPTOMS: A CANADIAN DESCRIPTIVE STUDY ASSESSING PREVALENCE, IMPACT AND SATISFACTION WITH TREATMENTS (2004) (1)
Eradication of Helicobacter pylori infection. Discussion (1996) (1)
Treatment of acute duodenal and pyloric channel ulcers with sucralfate suspension (2 g/10 ml) twice daily: efficacy in smoking patients (1993) (1)
Use of prescription and OTC drugs, nutritional supplements and naturopathic treatments for the irritable bowel syndrome (IBS): prevalence, satisfaction and adverse effects (2003) (1)
Acid suppression and ulcer healing: dichotomy, degree, and dilemma. (1988) (1)
The potential role of gastric epithelium in neutrophil recruitment, attachment and antigen presentation during Helicobacter pylori infection: In: Clinical Immunology Spectrum (1993) (1)
Non-selective nonsteroidal anti-inflammatory drugs (NSAIDs) and inflammatory bowel disease (IBD): a critical appraisal of the evidence (2003) (0)
Incidence of Endoscopic Gastric and Duodenal Ulcers (GDUs) in Randomized Placebo-Controlled NSAIDs Trials: A Meta-Analysis: 129 (2007) (0)
Helicobacter pylori and complicated ulcer disease. Discussion (1996) (0)
Subject Index, Vol. 51, Supplement 1, 1992 (1992) (0)
Helicobacter pylori and early gastric cancer: a pooled analysis (2003) (0)
PWE-078 Intragastric ph holding time of pH <4 predicts low erosive esophagitis healing rate (2010) (0)
Type B hepatitis infection risk in flexible fiberoptic endoscopy, A. Ayola, in: East Afr Med J, 57. (1980), 687 (1982) (0)
Defining Helicobacter pylori as a pathogen : Strain hetoerogeneity and virulence. Discussion (1996) (0)
Whistler Consensus (2007) (0)
The Effect of Nicotine and Indomethicin on Mucus Thickness in the Rat (1988) (0)
Synergy of high salt diet and infection with the sydney strain of Helicobacter pylori infection results in gastric mucosal dysplasia in mongolian gerbils (2003) (0)
Animal models of gastritis: Helicobacter pylori and high-salt diet in the gerbil (2003) (0)
Epidemic hypochlorhydria (1985) (0)
Subject Index Vol. 80, 2009 (2009) (0)
The value of colonoscopic brush biopsies in the assessment of recurrent carcinoma within the pelvis. (1986) (0)
The NERD Task Force: Overview and Consensus (2016) (0)
Immunomodulation of Helicobacter felis colonization of the mouse stomach (1998) (0)
Acid suppression. (1990) (0)
Omeprazole and acid inhibition : the essential issues ; 3 tables (1990) (0)
Su1777 Risk of Serious Upper Gastrointestinal (UGI) Complications With use of Non-Selective (NS) NSAIDs for at Least 4 Weeks Among Patients With a History of Peptic Ulcer (PU) or PU Complications: A Series of Systematic Reviews and Meta-Analyses (2012) (0)
Hemoclip for Peptic Ulcer Bleeding, a Meta-Analysis of Randomized Controlled Trials (2007) (0)
Screening and Diagnosis of Colorectal Cancer (1988) (0)
Optimization ofa MediumfortheRapidUreaseTestforDetection ofCampylobacter pylori inGastric Antral Biopsies (1989) (0)
Pharmacology and efficacy of cyclooxygenase (COX) inhibitors. Discussion (1999) (0)
Acid suppression (1990) (0)
Colonoscopy an essential monitoring technique after resection of colorectal cancer, S.W. Unger, H.J. Wanebo, in: Am J Surg, 145. (1983), 71 (1984) (0)
DoH2receptor antagonists havetobegiven atnight? A study oftheantisecretory profile ofSKF94482, a new H2receptor antagonist whichhasaprofound effect on daytime acidity (1989) (0)
Subject Index, Vol. 8, Supplement 1, 1990 (1990) (0)
Campylobacter pylori and trials of ulcer recurrence. (1989) (0)
Theeffect ofintravenous prostaglandin F2aandE2 onthemotility ofthesigmoid colon (1975) (0)
Effect of Aspirin and ibuprofen either alone or in combination on gastric mucosa and bleeding time and on serum prostaglandin E2 and thromboxane A2 levels in the anaesthetized rats in vivo (2017) (0)
Comparison of endoscopic polidocanol injection and Nd:YAG laser therapy for bleeding peptic ulcers, P. Rutgeerts, G. Van Trappen, L. Broechkaert, in: Lancet, 1. (1989), 1164 (1990) (0)
Introduction to Mechanisms of Injury and Sequelae of Helicobacter pylori Infection (1991) (0)
Hellcobacter pylori and peptic-ulcer disease. Author's relpy (2002) (0)
Practice audit in gastroEnterology—The PAGE program for upper GI endoscopy (EGD) (2003) (0)
Limited value of early endoscopy in the management of acute upper gastrointestinal bleeding: prospective controlled trial, D.Y. Graham, in: Am J Surg, 140. (1980), 284 (1981) (0)
Colorectal spirochetosis: report of 3 cases (1984) (0)
The host specific differences in physiology of acid secretion related to prostaglandins may bias toward Helicobacter related mucosal injury (2001) (0)
Olestra, a non digestible and nonabsorbable fat. (2000) (0)
GERD-related symptoms may be an indication for the concomitant presence of GERD in this patient population. (2006) (0)
Endoscopy and Biopsy in Gastroenterology (1981) (0)
WDHD 2012 summary and a glimpse into 2013 (2012) (0)
Treatment of low grade gastric MALT lymphoma with H. pylori eradication therapy (1998) (0)
The role of acid suppression in the treatment of H. pylori infection (1994) (0)
Horizons in gastroenterology : proceedings of an international meeting held in Evian, France, 21-24 June 1992 (1992) (0)
Helicobacter pylori and peptic-ulcer disease (2002) (0)
Mo1039 Communicating Gastrointestinal (GI) Symptoms: the Patient's Challenge (2012) (0)
OC-044 Antisecretory effects of Lactobacillus rhamnosus-conditioned medium prompts the notion of lactobacilli species as probiotics of the upper gastrointestinal tract (2010) (0)
Residual stalks of pedunculated adenomas: an under-recognized type of colonic polypJ Clin Gostroenterol, 227–231 (1988) (0)
A case of idiopathic respiratory distress syndrome (IRDS) treated with continuous positive airways pressure (CPAP). (1975) (0)
Hp and pH: Implications for the Eradication of Heliobacter pylori (1993) (0)
W1917 Endoscopic Gastroduodenal Ulcers (Gdus) in NSAID Arms in Randomized Placebo-Controlled NSAID Trials (Rcts): A Meta-Analysis (2008) (0)
Comprar Pharmacologic Therapies In Gastroenterology, An Issue Of Gastroenterology Clinics, Vol. 39-3 | Richard H. Hunt | 9781437725247 | Saunders (2010) (0)
Fungal infection associated with gastroduodenal ulceration: endoscopic and pathologic appearances, M. Peters, J. Weinen, C. Whelan, in: Gastroenterology, 78. (1980), 350 (1981) (0)
Acetaminophen and aminotransferase elevations. Authors' reply (2006) (0)
Comparative toxicity of nonsteroidal anti-inflammatory drugs. Discussion (1999) (0)
Non-variceal upper GI bleeding (2018) (0)
Testing for Helicobacter pylori in clinical practice. Discussion (1996) (0)
Discussion Practical Considerations Regarding Long-Term Treatment with Omeprazole (2004) (0)
Clinical pharmacology of gastrointestinal and liver disease. Preface. (2010) (0)
Massive bleeding from large bowel. (1980) (0)
Development of a new gastric antisecretory drug for clinical use (1991) (0)
Drug Therapy of (2004) (0)
Survey of management in acute upper gastrointestinal haemorrhage, G.E. Thomas, P.B. Cotton, C.G. Ciark, P.B. Bowles, in: J Roy soc Med, 73. (1980), 90 (1982) (0)
Reply (1989) (0)
Seminars on Ulcer Healing (1993) (0)
Endoscopic treatment versus conservative treatment in acute gallstone pancreatitis, J.P. Neoptolemos, D.L. Carr-Locke, N.J. London, in: Lancet, 2. (1988), 979 (1989) (0)
Reply (1989) (0)
Rectal bleeding. (1984) (0)
Massive bleeding from the large bowel. (1980) (0)
What’s New in the Stomach? A Report on the World Congress of Gastroenterology (1991) (0)
Helicobacter pylori : basic mechanisms to clinical cure, 1998 : the proceedings of a symposium (1998) (0)
Localization and Treatment of Small and Large Bowel Bleeding (1992) (0)
Communicating Gastrointestinal Symptoms: The Patient's Challenge. (2018) (0)
Inhibition of gastric acid secretion (1999) (0)
Asia-Pacific consensus on the management of gastroesophageal reflux disease: Update (Journal of Gastroenterology and Hepatology 22, (8-22) DOI: 10.1111/j.1440-1746.2007.05249.x) (2008) (0)
Screening by Colonoscopy - Has the Time Arrived? (1990) (0)
Medical and Surgical Therapy in Barrett's Esophagus (BE): Meta-Analyses Using Various Outcomes (2011) (0)
Discussion Acid-Related Diseases – New Perspectives (1992) (0)
Proximal gastric vagotomy versus truncal vagotomy and antrectomy (1984) (0)
Stomach and duodenum (1998) (0)
Chairman’s Summary (1990) (0)
The economics of eradicating Helicobacter pylory infection in duodenal ulcer disease. Discussion (1996) (0)
Y. YUAN*, Y.-H. YUAN, (2009) (0)
The Effect of Initial Treatment for Duodenal Ulcer on Subsequent Relapse Rates (1988) (0)
Helicobacter pylori and Malignant Diseases (1999) (0)
The Ulcer Story: The Authoritative Guide to Ulcers, Dyspepsia and Heartburn (1997) (0)
Report the Maastricht V / Florence Consensus − − infection Helicobacter pylori Management of (2016) (0)
Helicobacter pylori twenty years on. (2003) (0)
Fibreoptic endoscopy of the upper gastrointestinal tract and its application in the Royal Navy. (1975) (0)
Can canadian endoscopists predict lesions at upper GI endoscopy (EGD)? An evaluation of the ‘PAGE’ program (2003) (0)
Economic evaluation of Helicobacter pylori eradication in the management of duodenal ulcer (1996) (0)
Contents Vol. 80, 2009 (2009) (0)
Helicobacter pylori : basic mechanisms to clinical cure : proceedings of the international symposium held at Amelia Island, Florida, USA, November 3-6, 1993 (1994) (0)
M1921 Pantoprazole 20mg Versus 40mg Once Daily for Two Weeks for Heartburn or Reflux Symptoms Relief: A Meta-Analysis (2009) (0)
Enisoprost, a Synthetic Pge1 Derivative, is a Potent Inhibitor of Stimulated Gastric Acid and Pepsin Secretion in Man (1986) (0)
Panel Discussion: What is New in Etiology and Pathogenesis of Peptic Ulcer Disease? (1988) (0)
World Digestive Health Day From Heartburn to Constipation Common GI symptoms in the Community : Impact and Interpretation (2012) (0)
Epidemic hypochlorhydria, ethics committees, and protection for volunteers (1985) (0)
The true incidence of synchronous cancer of the large bowel, J.M. Langevin, S. Nivatvongs, in: Am J Surg, 147. (1984), 330 (1985) (0)
T1959 Prostaglandin Bx, An Inhibitor of Phospholipase A2, Reduces NSAID-Induced Gastric Damage in BALB/C Mice But Not in C57BL/6 Mice That Are Homozygous for a Disrupted sPLA2 Gene (2009) (0)
W1720 Gastric Hypersecretion Related to Cholinergic Hypersensitivity in the Flinders Rat Model of Depression Contributes to Stress Induced Ulceration of the Stomach (2008) (0)
Advances in Understanding Inflammation in Esophageal Disease (2012) (0)
Discussion. Acid suppression for the long-term management of reflux disease: Part 2 (1992) (0)
Spontaneous autoimmune gastritis and hypochlorhydria are manifest in the ileitis-prone SAMP1/YitFcs mice. (2012) (0)
Peptic ulcer disease : Defining the treatment strategies in the era of Helicobacter pylori. Discussion (1997) (0)
Clarithromycin-based triple therapies. (1999) (0)
ManagementofNSAIDinduced gastrointestinal disturbance (1987) (0)
Optimum treatment regimens for Helicobacter pylori infection (2000) (0)
Validation of the different methods used in the assessment of experimental ulcers in animals (1992) (0)
Are Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Associated With Esophageal Injury? A Systematic Review of Case-Control Studies (2011) (0)
of duodenal ulcer . receptor antagonist for the treatment Single nocturnal dose of an H 2 (2006) (0)
Cimetidine versus ranitidine for refractory Zollinger-Ellison syndrome. (1984) (0)
Table 1. Varlabiesfor Automatedenzymiccreatinineassaywith (2004) (0)
Nonsteroidal anti-inflammatory drugs and life-threatening complications of peptic ulceration, C.P. Armstrong, A.L. Blower, in: Gut, 28. (1987), 527 (1988) (0)
Evaluation of a Novel, Icon-Based Symptom Assessment Tool for Gastroenterology: 1775 (2015) (0)
Reply (1989) (0)
Endoscopy around the worldPorous containers for small biopsies, S. Colley, T. Gledhill, R. Bone, J. Burston, D.G. Colin-jones, in: Lancet, 1 (1982), pp. 773-774 (1982) (0)
Pathogenesis to prescription: progress in understanding and treating acid related disorders. (1996) (0)
The diagnosis and prognosis of upper gastrointestinal haemorrhage. (1980) (0)
Chromium 5 l-Labeled Ethylenediamine- tetraacetic Acid and Ovalbumin During Acute Inflammation and Anaphylaxis (1988) (0)
Clinical expressions of Helicobacter pylori infection. Discussion (1996) (0)
[Mechanism of proton pump inhibitors in the treatment of Holicobacter pylori-associated ulcers]. (1997) (0)
Inhibition ofurease activity butnotgrowth of Helicobacter pylori byacetohydroxamic acid (1991) (0)
Chronic gastrointestinal bleeding of obscure origin and small bowel enteroscopy, B.S. Lewis, J.D. Waye, in: Gastroenterology, 94. (1988), 1117 (1989) (0)
Safe Prescription of NSAIDs in Clinical Practice (2016) (0)
Incidence of endoscopic gastroduodenal ulcers(GDUS) in the placebo arms in randomized controlled NSAIDs trials—a meta-analysis (2003) (0)
Combination of pirenzepine and cimetidine in the therapy of duodenal ulcer. (1988) (0)
Su1614 Risk of Serious (UGI) Complications With Concomitant use of Non-Selective NSAIDs and Low-Dose Aspirin: A Series of Systematic Reviews of Randomized Controlled Trials (RCT), Cohort Studies and Case Control Studies (2012) (0)
Applications and Pitfalls of Endoscopy in Inflammatory Bowel Disease (1990) (0)
THE ROLE OF SEROLOGICAL SCREENING IN H. PYLORI MANAGEMENT (2000) (0)
Is There a Difference in the Prevalence of Helicobacter pylori Infection between Short-Segment and Long-Segment Barrettʼs Esophagus?: 44 (2007) (0)
INHIBITION OF HELICOBACTER PYLORI BY ACETOHYDROXAMIC ACID. COMMENT. AUTHORS' REPLY (1990) (0)
M1887 The Gain in Quality-Adjusted Life Years By Switching to Esomeprazole in Those with Persistent GERD Symptoms in Primary Care: EncomPASS - a Cluster-Randomized Trial (2009) (0)
Spontaneous Autoimmune Gastritis, Hypochlorhydria and Bacterial Overgrowth in the Ileitis-Prone, SAMP1/Yit Mice (2011) (0)
Acute onset of dyspnea associated with colonoscopy, J.R. Dexter, P.M. Gold, in: JAMA, 244. (1980), 1239 (1981) (0)
Environment and Lifestyle - Effects on Disorders of the Digestive Tract: Falk Symposium 176, Freiburg, October 2010 (2011) (0)
sup 14 C-urea breath test for the detection of Helicobacter pylori (1990) (0)
Correction to: Acid Suppressant Therapy: a Step Forward with Potassium-Competitive Acid Blockers (2021) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Richard H. Hunt?

Richard H. Hunt is affiliated with the following schools:

McMaster University